Authors:
ESSELL JH
SCHROEDER MT
HARMAN GS
HALVORSON R
LEW V
CALLANDER N
SNYDER M
LEWIS SK
ALLERTON JP
THOMPSON JM
Citation: Jh. Essell et al., URSODIOL PROPHYLAXIS AGAINST HEPATIC COMPLICATIONS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 128(12), 1998, pp. 975
Authors:
HARMAN GS
OMURA GA
RYAN K
HAINSWORTH JD
CRAMER MB
HAHNE WF
Citation: Gs. Harman et al., A RANDOMIZED, DOUBLE-BLIND COMPARISON OF SINGLE-DOSE AND DIVIDED MULTIPLE-DOSE DOLASETRON FOR CISPLATIN-INDUCED EMESIS, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 323-328
Citation: Ck. Lee et al., FATAL CYCLOPHOSPHAMIDE CARDIOMYOPATHY - ITS CLINICAL COURSE AND TREATMENT, Bone marrow transplantation, 18(3), 1996, pp. 573-577
Authors:
LEE CK
GINGRICH RD
HARMAN GS
HOHL RJ
SVSEL IA
FRANCY RJ
AJRAM KA
JOHANNSEN SM
Citation: Ck. Lee et al., GRAFT-VERSUS-HOST DISEASE AND SURVIVAL IN GRADED INCREMENTAL ADD-BACK(GIAB) FOR T-CELL DEPLETION-ALLOGENEIC BONE-MARROW TRANSPLANTATION (TCD-AL-BMT), COMPARED TO 2-LEVEL ADD-BACK (TLAB), Blood, 88(10), 1996, pp. 3777-3777
Authors:
LEE CK
GINGRICH RD
HARMAN GS
HOHL RJ
SYSEL IA
FRANCY RJ
AJRAM KA
JOHANNSEN SM
Citation: Ck. Lee et al., RISK FACTOR-DEPENDENT MODULATION OF GRAFT-VERSUS-HOST DISEASE (GVHD) BY GRADED INCREMENTAL T-CELL ADD-BACK (GIAB) IN T-CELL DEPLETION ALLOGENEIC BONE-MARROW TRANSPLANTATION (TCD-AL-BMT), Blood, 88(10), 1996, pp. 1662-1662
Citation: Ck. Lee et al., REDUCED LETHAL FUNGAL INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (AL-BMT) WITH T-CELL DEPLETION AND ADD-BACK (TCD-AB), Blood, 88(10), 1996, pp. 1663-1663
Authors:
GINGRICH RD
LEE CK
WEN BC
HARMAN GS
AJRAM KA
Citation: Rd. Gingrich et al., TOXICITY AND OUTCOME OF A NEW HIGH-DOSE, 4-DRUG ABLATIVE REGIMEN COMBINED WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL (HSC) RECONSTITUTION FOR PATIENTS WITH STAGE-IV BREAST-CANCER (ST4BC), Blood, 86(10), 1995, pp. 1530-1530
Authors:
LEE CK
GINGRICH RD
HARMAN GS
HOHL RJ
AIRAM KA
PADLEY DJ
HULING DA
TRIGG ME
Citation: Ck. Lee et al., ANTI-CD3 (OKT3) T-CELL DEPLETION AND ADD-BACK (TCD-AB) - COMPARATIVE-ANALYSIS WITH ANTI-CD2 (CT2) TCD-AB IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 2266-2266
Authors:
LEE CK
HARMAN GS
HOHL RJ
AJRAM KA
GINGRICH RD
Citation: Ck. Lee et al., EFFECTS OF T-CELL DOSE AND GVHD ON IMMUNE RECONSTITUTION IN CD2 T-CELL DEPLETION AND 2-LEVEL ADD-BACK (TCD-AB) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 2268-2268
Authors:
LEE CK
HAYASHI M
HARMAN GS
HOHL RJ
AJRAM KA
GINGRICH RD
Citation: Ck. Lee et al., ANTI-CD2 T-CELL DEPLETION WITH 2-LEVEL T-CELL ADDBACK (TCD-AB) IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (AL-BMT), Blood, 86(10), 1995, pp. 2269-2269
Authors:
SYSEL IA
LEE CK
FRANEY RJ
HARMAN GS
HOHL RJ
GINGRICH RD
Citation: Ia. Sysel et al., PULMONARY VENOOCCLUSIVE DISEASE (PVOD) IN THE ADULT BONE-MARROW TRANSPLANT POPULATION - 2 CASE-REPORTS, Blood, 86(10), 1995, pp. 3856-3856
Authors:
THOMAS AW
ACHUS ML
HARMAN GS
ALLERTON JP
CALLANDER NS
SNYDER MJ
ESSELL JH
HALVORSON RD
Citation: Aw. Thomas et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOLLOWING A CONDITIONINGREGIMEN OF BUSULFAN AND CYCLOPHOSPHAMIDE IN 4 PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA (PNH), Blood, 84(10), 1994, pp. 10000723-10000723
Authors:
COPELAN EA
BIGGS JC
SZER J
THOMPSON JM
CRILLEY P
BRODSKY I
KLEIN JL
KAPOOR N
HARMAN GS
AVALOS BR
Citation: Ea. Copelan et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA, ACUTE LYMPHOCYTIC-LEUKEMIA, AND MULTIPLE-MYELOMA FOLLOWING PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2), Seminars in oncology, 20(4), 1993, pp. 33-38